BIOSIG TECHNOLOGIES INC (BSGM) Stock Overview
USA - NASDAQ:BSGM - US09073N3008 - Common Stock
BSGM Key Statistics, Chart & Performance
The current stock price of BSGM is 6.1 USD. In the past month the price increased by 32.61%. In the past year, price increased by 256.73%.
BSGM Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.29 | 232.77B | ||
| ISRG | INTUITIVE SURGICAL INC | 55.86 | 161.20B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.17 | 143.29B | ||
| SYK | STRYKER CORP | 28.5 | 140.03B | ||
| MDT | MEDTRONIC PLC | 17.8 | 126.26B | ||
| BDX | BECTON DICKINSON AND CO | 13.45 | 55.03B | ||
| IDXX | IDEXX LABORATORIES INC | 52.27 | 50.22B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.79 | 44.95B | ||
| RMD | RESMED INC | 29.46 | 41.20B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.4 | 34.89B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.59 | 27.00B | ||
| DXCM | DEXCOM INC | 39.04 | 26.02B |
Related stock screener links
About BSGM
Company Profile
BioSig Technologies, Inc. is a medical technology company, which engages in the development of a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiographic and intra-cardiac signals. The company is headquartered in Westport, Connecticut and currently employs 5 full-time employees. The company went IPO on 2014-09-22. The firm has an advanced digital signal processing technology platform, the PURE EP Platform (PURE EP), that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. PURE EP is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures, such as environmental lab noise from other equipment, signal saturation, slow signal recovery, and inaccurate display of fractionated potentials. PURE EP is a signal processing platform that combines advanced hardware and software to address known challenges associated to signal acquisition, to enable electrophysiologists to see more signals and analyze them in real-time. PURE EP is designed to enhance clinical decision-making and improve clinical workflows for all types of arrhythmias, even the challenging procedures for cardiac arrhythmias, like ventricular tachycardia and atrial fibrillation.
Company Info
BIOSIG TECHNOLOGIES INC
55 Greens Farms Road
Westport CONNECTICUT 06880 US
CEO: Kenneth L. Londoner
Employees: 5
Phone: 12034095444
BIOSIG TECHNOLOGIES INC / BSGM FAQ
What is the stock price of BIOSIG TECHNOLOGIES INC today?
The current stock price of BSGM is 6.1 USD. The price increased by 37.08% in the last trading session.
What is the ticker symbol for BIOSIG TECHNOLOGIES INC stock?
The exchange symbol of BIOSIG TECHNOLOGIES INC is BSGM and it is listed on the Nasdaq exchange.
On which exchange is BSGM stock listed?
BSGM stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for BIOSIG TECHNOLOGIES INC stock?
7 analysts have analysed BSGM and the average price target is 10.2 USD. This implies a price increase of 67.21% is expected in the next year compared to the current price of 6.1. Check the BIOSIG TECHNOLOGIES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is BIOSIG TECHNOLOGIES INC worth?
BIOSIG TECHNOLOGIES INC (BSGM) has a market capitalization of 880.47M USD. This makes BSGM a Small Cap stock.
How many employees does BIOSIG TECHNOLOGIES INC have?
BIOSIG TECHNOLOGIES INC (BSGM) currently has 5 employees.
What are the support and resistance levels for BIOSIG TECHNOLOGIES INC (BSGM) stock?
BIOSIG TECHNOLOGIES INC (BSGM) has a support level at 4.18 and a resistance level at 6.11. Check the full technical report for a detailed analysis of BSGM support and resistance levels.
Should I buy BIOSIG TECHNOLOGIES INC (BSGM) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BSGM, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BSGM, evaluating the profitability, health, valuation and growth aspects
- BIOSIG TECHNOLOGIES INC (BSGM) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BIOSIG TECHNOLOGIES INC (BSGM) Sales and EPS estimates to see what analysts future expectations are.
- BIOSIG TECHNOLOGIES INC (BSGM) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BIOSIG TECHNOLOGIES INC (BSGM) Insider and Institutional Ownership to learn about the owners and their transactions.
- BIOSIG TECHNOLOGIES INC (BSGM) Stock Chart to make your own analysis
- BIOSIG TECHNOLOGIES INC (BSGM) Latest news and press-releases to stay up to date.
Does BIOSIG TECHNOLOGIES INC (BSGM) stock pay dividends?
BSGM does not pay a dividend.
When does BIOSIG TECHNOLOGIES INC (BSGM) report earnings?
BIOSIG TECHNOLOGIES INC (BSGM) will report earnings on 2025-11-12.
What is the Price/Earnings (PE) ratio of BIOSIG TECHNOLOGIES INC (BSGM)?
BIOSIG TECHNOLOGIES INC (BSGM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.81).
BSGM Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to BSGM. When comparing the yearly performance of all stocks, BSGM is one of the better performing stocks in the market, outperforming 97.09% of all stocks.
BSGM Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to BSGM. Both the profitability and financial health of BSGM have multiple concerns.
BSGM Financial Highlights
Over the last trailing twelve months BSGM reported a non-GAAP Earnings per Share(EPS) of -0.81. The EPS increased by 80.81% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -23.52% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
BSGM Forecast & Estimates
7 analysts have analysed BSGM and the average price target is 10.2 USD. This implies a price increase of 67.21% is expected in the next year compared to the current price of 6.1.